Skip to main navigation
  • Investor Home
  • News & Presentations
    News Events Presentations
  • Governance
    Governance Overview Board of Directors Leadership Our ESG Philosophy
  • Financials
    SEC Filings Quarterly Results Annual Reports
  • Stock Information
    Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
  • Resources
    Pipeline Investor FAQs Email Alerts Contact IR

News Releases


Feb 03, 2023

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read More

Jan 14, 2023

Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of

Read More

Jan 05, 2023

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read More
  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
Displaying 19 - 21 of 21
Print Page
RSS Feeds
Email Alerts
Search
Arcutis Biotherapeutics logo
  • Contact

 (805) 418-5006
 emcintyre@arcutis.com

  • Legal Disclaimer
  • Privacy Notice
  • Cookie Settings

Social Links

  • LinkedIn
  • Twitter
© 2023 Arcutis Biotherapeutics